Active ingredient
Baricitinib
4 finished FDA listings contain Baricitinib as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- BARICITINIB
- Dosage forms
- Tablet, Film Coated
- Routes
- Oral
- Manufacturers / labelers
- 1
- Strengths listed
- 1 mg/1 · 2 mg/1 · 4 mg/1
- Brand names in FDA listings
- Olumiant
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2047232
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 207924 | ELI LILLY AND CO | 2018-05-31 | 3 |
Official labeling on DailyMed
- OLUMIANT (BARICITINIB) TABLET, FILM COATED [ELI LILLY AND COMPANY] · version 30 · 2026-07-14
- BARICITINIB TABLET, FILM COATED [ELI LILLY AND COMPANY] · version 3 · 2022-06-14
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.